Table 2

The proportion of reported general, musculoskeletal symptoms, pharyngalgia and rhinorrhoea in patients with COVID-19 at baseline by continent

RefGeneral symptomsMusculoskeletal symptomsPharyngalgia/
pharyngitis/
sore throat
Rhinorrhoea/
runny nose
FeverFatiguePoor appetite/
anorexia
ChillsDizziness/
drowsy
HeadacheMyalgia/
muscle ache
America (North)104817*NDNDNDNDND30ND
1568NDDNQDNQ
1152NDNDND
Range(48-68)(17)(30)DNQ
Asia9NDNDNDNDNDNDNDNDND
26893811415‡14
38934621ND8112152
558226NDNDNDNDNDND
438716311§11**67
449432†NDNDND32§NDND
45942315
47NDNDND
2781733221061‡
2277NDND14ND9314
36927512NDNDNDND
199970409717
348232†NDND1032¶ND
498933†43333¶18
56DNQNDNDNDNDND
578739131113
177817†ND17¶12
3983ND81154
41714425NDNDNDND
5887NDND11187
597821742826
2573ND1ND26NDND26
3779NDND1623146
48DNQNDNDNDND
60937527
50194210714309
428723NDNDND32ND
297752†3452¶
798571320ND16
40799NDNDNDND5††
184ND2ND
3098612ND6
20674ND166ND
289631†1816§16**
31¶
64††
618633NDNDNDNDNDND
629844†844¶
249465†665¶
468416†316¶
1378NDND11
12DNQDNQDNQND
886524329ND2419
636714NDND1414ND
35791111ND21
217489NDND
671471224612
1692NDND2323ND8
238342033ND
6473NDND279
65DNQDNQDNQDNQNDDNQDNQ
32NDNDNDDNQNDND
313218111432
3372NDNDND616
Range(4–99))(4–89)(1–43)(1–42)(2–16)(0–34)(3–65)(2–61)(2–26)
Europe1469NDNDNDND21377
Range69ND(21)377
Range(4–99)(4–89)(1–43)(1–42)(2–16)(0–34)(3–65)(2–61)(2–26)
  • *Or malaise.

  • †Or myalgia.

  • ‡Or arthralgia.

  • §Or headache.

  • ¶Or fatigue.

  • **Or dizziness.

  • ††Or nose congestion.

  • DNQ, described but not quantified; ND, not described; Ref, reference.